Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.1956 USD | -6.41% | -11.53% | -84.60% |
30.04. | Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
23.04. | Transcript : CNS Pharmaceuticals, Inc. - Special Call |
Kurzporträt
Mitarbeiterzahl: 4
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 01.09.17 |
Director of Finance/CFO | 45 | 13.11.19 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01.12.17 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01.01.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01.01.18 |
John Climaco
CEO | Chief Executive Officer | 55 | 01.09.17 |
Faith Charles
CHM | Chairman | 62 | 03.01.23 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 25.06.18 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 08.05.23 |
Jerzy Gumulka
BRD | Director/Board Member | 74 | 08.11.17 |
Amy Mahery
BRD | Director/Board Member | 47 | 18.01. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 10 634 932 | 9 621 176 ( 90,47 %) | 0 | 90,47 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-84.60% | 2.22 Mio. | |
+17.96% | 47.02 Mrd. | |
+48.77% | 41.86 Mrd. | |
+1.17% | 41.76 Mrd. | |
-4.27% | 28.8 Mrd. | |
+11.42% | 26.05 Mrd. | |
-21.39% | 19.15 Mrd. | |
+4.86% | 12.55 Mrd. | |
+27.29% | 12.34 Mrd. | |
-3.50% | 11.82 Mrd. |
- Börse
- Aktien
- A3D2GF Aktie
- Unternehmen CNS Pharmaceuticals, Inc.